872728-85-3

872728-85-3 structure
872728-85-3 structure

Name N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]arbonyl]-N-2-pyridin
Synonyms Dabigatran ethyl ester tosylate
Dabigatran Impurity 16 p-Toluenesulfonate
Ethyl 3-(((2R,3S,4R)-1-(2-(((4-cbamimidoylphenyl)amino)methyl)-1-methyl-1H-benzo[d]imidazol
N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]bonyl]-N-2-pyridinyl-beta-alanine ethyl ester 4-methylbenzenesulfona
Dabigatran etexilate/N-2
Ethyl 3-{[(2R,3S,4R)-1-(2-{[(4-carbamimidoylphenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)-2,3,4,5-tetrahydroxypentyl](2-pyridinyl)amino}propanoate 4-methylbenzenesulfonate (1:1) (non-preferred name)
N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]bonyl]-N-2-pyridin
Alanine,N- 2- 4-(aMinoiMinoMethyl)phenyl amino Methyl -1-Methyl-1H-benziMidazol-5-yl carbonyl -N-2-pyridinyl-,ethyl ester,4-Methylbenzenesulfonate(1 1)
N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]bonyl]-N-2-pyridinyl-beta-alanine ethyl ester 4-methylbenzenesulfonate
Dabigatran impurity 26/Dabigatran ethyl ester tosylate/1-methyl-2-[N-[4-amidinophenyl]aminomethyl]benzimidazole-5-cboxylic acid N-(2-pyridyl)-N-(2-ethoxycbonylethyl)amide tosylate
β-Alanine, N-[[2-[[[4-(aMinoiMinoMethyl)phenyl]amino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester, 4-Methylbenzenesulfonat
D-Arabinitol, 1-[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]-1-deoxy-1-[(3-ethoxy-3-oxopropyl)-2-pyridinylamino]-, (1ξ)-, 4-methylbenzenesulfonate (1:1)
InterMediates of Dabigatran
Dabigatran etexilate-18
1-methyl-2-[N-[4-amidinophenyl]aminomethyl]benzimidazol-5-yl-carboxylicacid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)amide para-toluene sulfonate
Dabigatran etexilate impurity176
Ethyl 3-(2-(((4-cbaMiMidoylphenyl)amino)Methyl)-1-Methyl-N-(pyridin-2-yl)-1H-benzo[d]iMidazole-5-cboxaMido)propanoate 4-Methylbenzenesulfonate
Dabigatran Impurity 59
DB-7
N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1
Dabigatran ester impurity 18
N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]bonyl]-N-2-pyridinyl-beta-alanine ethyl ester 4-methylbenzenesulfonate //BP
N-[[2-[[[4-(AMinoiMinoMethyl)phenyl]amino]Methyl]-1- Methyl-1H-benziMidazol-5-yl] carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester 4-Methylbenzenesulfonate
1-methyl-2-[N-[4-amidinophenyl]aminomethyl]benzimidazole-5-carboxylic acid N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)amide tosylate
N-[[2-[[[4-(AMinoiMinoMethyl)phenyl]amino]Methyl]-1- Methyl-1H-benziMidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester tosylate
Molecular Formula C38H47N7O9S
Molecular Weight 777.886
Exact Mass 777.315613
PSA 265.82000
LogP 4.63590

~92%

872728-85-3 structure

872728-85-3

Literature: BOEHRINGER INGELHEIM INTERNATIONAL GMBH; BOEHRINGER INGELHEIM PHARMA GMBH and CO. KG Patent: WO2007/71742 A1, 2007 ; Location in patent: Page/Page column 25 ;
Precursor  2

DownStream  1

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.